{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:52:15Z","timestamp":1793731935657,"version":"4.6.1"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.vaccine.2009.09.107","type":"journal-article","created":{"date-parts":[[2009,12,12]],"date-time":"2009-12-12T09:18:19Z","timestamp":1260609499000},"page":"G72-G81","source":"Crossref","is-referenced-by-count":100,"special_numbering":"S6","title":["Development of a rotavirus vaccine: Clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq\u00ae"],"prefix":"10.1016","volume":"27","author":[{"given":"Max","family":"Ciarlet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Sch\u00f6del","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2009.09.107_bib1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3201\/eid1202.050006","article-title":"Rotavirus and severe childhood diarrhea","volume":"12","author":"Parashar","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.107_bib2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3201\/eid0905.020562","article-title":"Global illness and deaths caused by rotavirus disease in children","volume":"9","author":"Parashar","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"17","key":"10.1016\/j.vaccine.2009.09.107_bib3","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1001\/jama.279.17.1371","article-title":"Cost-effectiveness analysis of a rotavirus immunization program for the United States","volume":"279","author":"Tucker","year":"1998","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.107_bib4","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1542\/peds.2006-2876","article-title":"Cost-effectiveness and potential impact of rotavirus vaccination in the United States","volume":"119","author":"Widdowson","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2009.09.107_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2431-9-11","article-title":"The impact of rotavirus gastroenteritis on the family","volume":"9","author":"Mast","year":"2009","journal-title":"BMC Pediatr"},{"issue":"32","key":"10.1016\/j.vaccine.2009.09.107_bib6","first-page":"33","article-title":"WHO position paper on rotavirus vaccines","volume":"82","author":"World Health Organization","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.107_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/rmv.448","article-title":"Global distribution of rotavirus serotypes\/genotypes and its implication for the development and implementation of an effective rotavirus vaccine","volume":"15","author":"Santos","year":"2005","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2009.09.107_bib8","series-title":"Viruses in the environment","first-page":"171","article-title":"Emerging human rotavirus genotypes","author":"Matthijnssens","year":"2008"},{"key":"10.1016\/j.vaccine.2009.09.107_bib9","series-title":"Encyclopedia of environmental microbiology","first-page":"2753","article-title":"Rotaviruses: basic biology, epidemiology and methodologies","author":"Ciarlet","year":"2002"},{"issue":"8","key":"10.1016\/j.vaccine.2009.09.107_bib10","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00705-008-0155-1","article-title":"Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments","volume":"153","author":"Matthijnssens","year":"2008","journal-title":"Arch Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.107_bib11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.virol.2008.11.026","article-title":"Characterization of novel VP7, VP4, and VP6 genotypes of a previously untypeable group A rotavirus","volume":"385","author":"Solberg","year":"2009","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.107_bib12","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.virol.2009.01.040","article-title":"Evidence of interspecies transmission and reassortment among avian group A rotaviruses","volume":"386","author":"Schumann","year":"2009","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.vaccine.2009.09.107_bib13","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00705-009-0439-0","article-title":"Molecular analysis of the VP7 gene of pheasant rotaviruses identifies a new genotype, designated G23","volume":"154","author":"Ursu","year":"2009","journal-title":"Arch Virol"},{"issue":"8354","key":"10.1016\/j.vaccine.2009.09.107_bib14","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(83)90734-1","article-title":"Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children","volume":"2","author":"Vesikari","year":"1983","journal-title":"Lancet"},{"issue":"8384","key":"10.1016\/j.vaccine.2009.09.107_bib15","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(84)92323-7","article-title":"Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine","volume":"1","author":"Vesikari","year":"1984","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.107_bib16","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/infdis\/153.5.832","article-title":"A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children","volume":"153","author":"Vesikari","year":"1986","journal-title":"J Infect Dis"},{"issue":"8498","key":"10.1016\/j.vaccine.2009.09.107_bib17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0140-6736(86)91643-0","article-title":"Failure of live, attenuated oral rotavirus vaccine","volume":"2","author":"De Mol","year":"1986","journal-title":"Lancet"},{"issue":"8546","key":"10.1016\/j.vaccine.2009.09.107_bib18","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(87)90649-0","article-title":"Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants","volume":"1","author":"Hanlon","year":"1987","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.107_bib19","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/infdis\/159.3.452","article-title":"Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine","volume":"159","author":"Lanata","year":"1989","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.107_bib20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/infdis\/163.3.483","article-title":"A field study of the safety and efficacy of two candidate rotavirus vaccines in a native American population","volume":"163","author":"Santosham","year":"1991","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.107_bib21","first-page":"350","article-title":"Immune response of infants and children to low-passage bovine rotavirus (strain WC3)","volume":"140","author":"Clark","year":"1986","journal-title":"Am J Dis Child"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.107_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1023\/A:1014512314545","article-title":"Sequence analysis of the VP4, VP6, VP7 and NSP4 gene products of the bovine rotavirus WC3","volume":"24","author":"Ciarlet","year":"2002","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2009.09.107_bib23","series-title":"Vaccines","first-page":"809","article-title":"Rotavirus vaccines","author":"Clark","year":"1994"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.107_bib24","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/infdis\/158.3.570","article-title":"Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season","volume":"158","author":"Clark","year":"1988","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.107_bib25","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/infdis\/162.5.1055","article-title":"Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants","volume":"162","author":"Bernstein","year":"1990","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.107_bib26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0923-2516(91)90008-Q","article-title":"Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa","volume":"142","author":"Georges-Courbot","year":"1991","journal-title":"Res Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.107_bib27","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/infdis\/153.5.823","article-title":"Evaluation of rhesus rotavirus vaccine (MMU 18006) in infants and young children","volume":"153","author":"Anderson","year":"1986","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.107_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/archpedi.1990.02150270035021","article-title":"Clinical trial in children vaccinated between 2 and 5 months of age","volume":"144","author":"Vesikari","year":"1990","journal-title":"Am J Dis Child"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.107_bib29","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/infdis\/159.4.753","article-title":"Prolonged efficacy of rhesus rotavirus vaccine in Swedish children","volume":"159","author":"Gothefors","year":"1989","journal-title":"J Infect Dis"},{"issue":"8538","key":"10.1016\/j.vaccine.2009.09.107_bib30","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(87)92858-3","article-title":"Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants","volume":"1","author":"Flores","year":"1987","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.107_bib31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/JCM.28.3.553-558.1990","article-title":"Clinical studies of a quadrivalent rotavirus vaccine in Venezuelan infants","volume":"28","author":"P\u00e9rez-Schael","year":"1990","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2009.09.107_bib32","series-title":"Fields virology","first-page":"1917","article-title":"Rotaviruses","author":"Estes","year":"2007"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.107_bib33","first-page":"7","article-title":"Safety and efficacy of high-dose rhesus\u2013human reassortant rotavirus vaccines\u2014report of the national multicenter trial","volume":"97","author":"Rennels","year":"1996","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.107_bib34","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0022-3476(97)70076-3","article-title":"Efficacy and safety of high-dose rhesus\u2013human reassortant rotavirus vaccine in Native American populations","volume":"131","author":"Santosham","year":"1997","journal-title":"J Pediatr"},{"issue":"9086","key":"10.1016\/j.vaccine.2009.09.107_bib35","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(97)05118-0","article-title":"Randomized placebo-controlled trial of rhesus\u2013human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis","volume":"350","author":"Joensuu","year":"1997","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.vaccine.2009.09.107_bib36","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJM199710233371701","article-title":"Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela","volume":"337","author":"P\u00e9rez-Schael","year":"1997","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.107_bib37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0264-410X(90)90089-5","article-title":"Serotype 1 reassortant of bovine rotavirus WC3, strain WI79-9, induces a polytypic antibody response in infants","volume":"8","author":"Clark","year":"1990","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2009.09.107_bib38","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/infdis\/161.6.1099","article-title":"Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3","volume":"161","author":"Clark","year":"1990","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2009.09.107_bib39","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1093\/infdis\/174.Supplement_1.S73","article-title":"The development of a multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants","volume":"174","author":"Clark","year":"1996","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.107_bib40","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00006454-199504000-00010","article-title":"Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants","volume":"14","author":"Treanor","year":"1995","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"10.1016\/j.vaccine.2009.09.107_bib41","first-page":"116","article-title":"The pentavalent rotavirus vaccine: discovery to licensure and beyond","volume":"45","author":"Heaton","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 10","key":"10.1016\/j.vaccine.2009.09.107_bib42","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1097\/01.inf.0000142370.16514.4a","article-title":"A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis","volume":"23","author":"De Vos","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.107_bib43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Safety and efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine in preventing rotavirus gastroenteritis and reducing associated healthcare resource utilization","volume":"354","author":"Vesikari","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.107_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa052434","article-title":"Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis","volume":"354","author":"Ruiz-Palacios","year":"2006","journal-title":"New Engl J Med"},{"issue":"52","key":"10.1016\/j.vaccine.2009.09.107_bib45","doi-asserted-by":"crossref","first-page":"8756","DOI":"10.1016\/j.vaccine.2007.10.036","article-title":"Effectiveness of Lanzhou lamb rotavirus vaccine against rotavirus gastroenteritis requiring hospitalization: a matched case\u2013control study","volume":"25","author":"Fu","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.107_bib46","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s11262-008-0257-6","article-title":"Genomic characterization of a novel group a lamb rotavirus strain isolated in Zaragoza, Spain","volume":"37","author":"Ciarlet","year":"2008","journal-title":"Virus Genes"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.107_bib47","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/505151","article-title":"Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus\u2013rhesus\u2013human rotavirus reassortant tetravalent vaccines in Finnish children","volume":"194","author":"Vesikari","year":"2006","journal-title":"J Infect Dis"},{"issue":"23\u201324","key":"10.1016\/j.vaccine.2009.09.107_bib48","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/S0264-410X(02)00235-9","article-title":"Early phase II trial of human rotavirus vaccine candidate RV3","volume":"20","author":"Barnes","year":"2002","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.107_bib49","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1086\/600104","article-title":"A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial","volume":"200","author":"Bhandari","year":"2009","journal-title":"J Infect Dis"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2009.09.107_bib50","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1016\/S0264-410X(02)00315-8","article-title":"Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses","volume":"20","author":"Choi","year":"2002","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2009.09.107_bib51","doi-asserted-by":"crossref","first-page":"9233","DOI":"10.1128\/JVI.72.11.9233-9246.1998","article-title":"Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity","volume":"72","author":"Ciarlet","year":"1998","journal-title":"J Virol"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2009.09.107_bib52","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1016\/S0264-410X(03)00308-6","article-title":"Immunogenicity and protective efficacy of rotavirus 2\/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice","volume":"21","author":"Bertolotti-Ciarlet","year":"2003","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2009.09.107_bib53","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1128\/JVI.74.19.8843-8853.2000","article-title":"Intranasal administration of 2\/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs","volume":"74","author":"Yuan","year":"2000","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.107_bib54","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jpeds.2003.10.054","article-title":"Safety, efficacy and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants","volume":"144","author":"Clark","year":"2004","journal-title":"J Pediatr"},{"issue":"22","key":"10.1016\/j.vaccine.2009.09.107_bib55","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1016\/j.vaccine.2006.03.025","article-title":"Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety, and immunogenicity in healthy infants","volume":"24","author":"Vesikari","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.107_bib56","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/01.inf.0000091887.48999.77","article-title":"Safety, immunogenicity, and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer\/buffer liquid formulation","volume":"22","author":"Clark","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.107_bib57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1542\/peds.2006-2058","article-title":"Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life","volume":"119","author":"Block","year":"2007","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.vaccine.2009.09.107_bib58","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/INF.0b013e31814521cb","article-title":"Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants","volume":"26","author":"Goveia","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2009.09.107_bib59","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/S1201-9712(07)60020-4","article-title":"The integrated phase III safety profile of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine","volume":"11","author":"Dennehy","year":"2007","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.107_bib60","unstructured":"RotaTeq [prescribing information]. Whitehouse Station, NJ: Merck & Co., Inc.; 2009."},{"key":"10.1016\/j.vaccine.2009.09.107_bib61","first-page":"pw69","article-title":"RotaTeq\u00ae reduced hospitalizations and emergency department visits for rotavirus acute gastroenteritis: assessing the robustness of the results","volume":"93","author":"Vesikari","year":"2008","journal-title":"Arch Dis Child"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2009.09.107_bib62","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/INF.0b013e318168d29e","article-title":"Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequency","volume":"27","author":"Goveia","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"14","key":"10.1016\/j.vaccine.2009.09.107_bib63","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJM199610033351404","article-title":"Rotavirus infection in infants as a protection against subsequent infections","volume":"335","author":"Vel\u00e1zquez","year":"1996","journal-title":"N Engl J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2009.09.107_bib64","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S1201-9712(07)60019-8","article-title":"Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization based on data from 11 countries","volume":"11","author":"Vesikari","year":"2007","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.09.107_bib65","first-page":"pw70","article-title":"Efficacy of RotaTeq\u00ae, the pentavalent rotavirus vaccine, between doses: potential benefits of early protection","volume":"93","author":"Vesikari","year":"2008","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2009.09.107_bib66","first-page":"espnic5","article-title":"Efficacy of pentavalent rotavirus vaccine. RotaTeq\u2122, against hospitalizations and emergency department visits up to three years: the Finnish extension study","volume":"93","author":"Vesikari","year":"2008","journal-title":"Arch Dis Child"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.107_bib67","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.inf.0000254391.71103.e8","article-title":"Concomitant use of an oral live pentavalent human-bovine reassortant rotavirus vaccine with licensed parenteral vaccines in the United States","volume":"26","author":"Rodriguez","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.107_bib68","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/INF.0b013e31815aba79","article-title":"Immunogenicity and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy infants in Korea","volume":"27","author":"Kim","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2009.09.107_bib69","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/INF.0b013e3181782780","article-title":"Concomitant use of the oral pentavalent human bovine reassortant rotavirus vaccine and oral poliovirus vaccine","volume":"27","author":"Ciarlet","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.107_bib70","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0929-6646(09)60067-X","article-title":"Experience of pentavalent human-bovine reassortant rotavirus vaccine among healthy infants in Taiwan","volume":"108","author":"Chang","year":"2009","journal-title":"J Formos Med Assoc"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.107_bib71","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/INF.0b013e31818c0161","article-title":"Concomitant use of the 3-dose oral pentavalent rotavirus vaccine with a 3-dose primary vaccination course of a diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type b vaccine: immunogenicity and reactogenicity","volume":"28","author":"Ciarlet","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2009.09.107_bib72","first-page":"pw72","article-title":"Co-administration of pentavalent rotavirus vaccine. RotaTeq\u00ae, with meningococcal group c conjugate vaccine: immunogenicity and safety","volume":"93","author":"Vesikari","year":"2008","journal-title":"Arch Dis Child"},{"issue":"32","key":"10.1016\/j.vaccine.2009.09.107_bib73","first-page":"285","article-title":"Rotavirus vaccines","volume":"82","author":"World Health Organization","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"issue":"23","key":"10.1016\/j.vaccine.2009.09.107_bib74","first-page":"220","article-title":"Meeting of the immunization strategic advisory group of experts, April 2009\u2014conclusions and recommendations","volume":"84","author":"World Health Organization","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"issue":"21","key":"10.1016\/j.vaccine.2009.09.107_bib75","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1001\/jama.2009.756","article-title":"Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua","volume":"301","author":"Patel","year":"2009","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.vaccine.2009.09.107_bib76","first-page":"697","article-title":"Delayed onset and diminished magnitude of rotavirus activity\u2014United States, November 2007\u2013May 2008","volume":"57","author":"Centers for Disease Control","year":"2008","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2009.09.107_bib77","series-title":"Abstract presented at the joint 48th annual interscience conference on antimicrobial agents and chemotherapy (ICAAC) and 46th annual meeting of the Infectious Diseases Society of America (IDSA)","article-title":"Post-licensure effectiveness of RotaTeq\u00ae in preventing gastroenteritis","author":"Mast","year":"2008"},{"key":"10.1016\/j.vaccine.2009.09.107_bib78","series-title":"Abstract presented at the joint 48th annual interscience conference on antimicrobial agents and chemotherapy (ICAAC) and 46th annual meeting of the Infectious Diseases Society of America (IDSA)","article-title":"Effectiveness of pentavalent rotavirus vaccine (RV5) in US clinical practice","author":"Boom","year":"2008"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.107_bib79","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CVI.00382-08","article-title":"Decline in cases of rotavirus gastroenteritis presenting to The Children's Hospital of Philadelphia after introduction of pentavalent rotavirus vaccine","volume":"16","author":"Clark","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2009.09.107_bib80","series-title":"Abstract presented at the joint 48th annual interscience conference on antimicrobial agents and chemotherapy (ICAAC) and 46th annual meeting of the Infectious Diseases Society of America (IDSA)","article-title":"Epidemiology of rotavirus-associated hospitalizations pre- and post-implementation of immunization","author":"Daskalaki","year":"2008"},{"key":"10.1016\/j.vaccine.2009.09.107_bib81","series-title":"48th interscience conference on antimicrobial agents and chemotherapy (ICAAC)\/46th Infectious Diseases Society of America (IDSA)","first-page":"356","article-title":"Fewer 2008 hospitalizations for rotavirus (RV) in Kansas City, two years post RV vaccine","author":"Harrison","year":"2008"},{"key":"10.1016\/j.vaccine.2009.09.107_bib82","series-title":"48th interscience conference on antimicrobial agents and chemotherapy (ICAAC)\/46th Infectious Diseases Society of America (IDSA)","first-page":"357","article-title":"Rapid decline in pediatric rotavirus cases following introduction of rotavirus vaccine","author":"Hatch","year":"2008"},{"key":"10.1016\/j.vaccine.2009.09.107_bib83","series-title":"48th interscience conference on antimicrobial agents and chemotherapy (ICAAC)\/46th Infectious Diseases Society of America (IDSA)","first-page":"356","article-title":"Reduction of severe rotavirus gastroenteritis following routine use of luve, oral, pentavalent rotavirus vaccine","author":"Patel","year":"2008"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09014650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09014650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:00:35Z","timestamp":1634342435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09014650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":83,"alternative-id":["S0264410X09014650"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.09.107","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}